SLC5A2 and urinary tract infection: Despite the relatively low incidence of urinary tract infections associated with SGLT2 inhibitors, this study describes the case of renal abscess diagnosed in a patient treated with Dapagliflozin for HF with reduced ejection fraction with no other previous risk factors.